Rock Springs Capital Management’s AnaptysBio ANAB Stock Holding History
Bought
Maintained
Sold
Other funds holding ANAB
EC
TCM
DTC
BC
B
FLSM
GPP
Rock Springs Capital Management's ANAB Position: Q3 2023 in Review
Rock Springs Capital Management sold out of AnaptysBio (ANAB) in Q3 2023, closing a stake of 341,637 shares — an estimated $6.95M sold.
Rock Springs Capital Management first reported a position in ANAB in Q3 2017 and held it in 24 quarters. The position peaked at $18.7M in Q4 2021. 116 funds tracked by Wall St. Rank hold ANAB as of Q3 2023.
- Rock Springs Capital Management reported no remaining AnaptysBio position as of Q3 2023 after selling out during the quarter.
- Rock Springs Capital Management sold 341,637 AnaptysBio shares in Q3 2023, an estimated $6.95M.
- Rock Springs Capital Management first reported a position in AnaptysBio in Q3 2017 and held it in 24 quarters.
- Rock Springs Capital Management's AnaptysBio position peaked at $18.7M in Q4 2021.
- 116 funds tracked by Wall St. Rank held AnaptysBio as of Q3 2023.
Based on Rock Springs Capital Management's 13F filing for Q3 2023, filed 14 Nov 2023.